AwardTape · Defense awards · Research and development · Health R&D · W81XWH17C0065
W81XWH17C0065: -$550K definitive contract to Xequel Bio, Inc
Xequel Bio, Inc holds a definitive contract from Department of the Army with -$550K obligated since Oct 2023 and $1000K obligated over its life, against a ceiling of $1000K. Latest action Jan 16, 2025.
Igf::ot::igf DHA sbir ph ii proposal no. a2-6647
| PIID | W81XWH17C0065 |
|---|---|
| Type | definitive contract |
| Company | Xequel Bio, Inc |
| Agency | Department of the Army |
| Contracting office | W4PZ USA MED RSCH ACQUIS ACT |
| Category | Research and development · Health R&D |
| PSC | AN91 OTHER MEDICAL (BASIC) |
| NAICS | 541711 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY |
| Obligated since Oct 2023 | -$550K |
| Total obligated (lifetime) | $1000K |
| Ceiling (base and all options) | $1000K |
| Base date | Sep 25, 2017 |
| Latest action | Jan 16, 2025 |
| End date | Sep 27, 2022 |
| Actions since Oct 2023 | 1 |
| Pricing | Cost no fee |
| Competition | Competed after exclusion of sources |
| Place of performance | SC |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial